Evidence map›Paper›PMID 40709581›Full record

ArticleJournal of global health2025

Therapeutic plasma exchange in critically ill patients in low-income and lower-middle-income countries: medical need and feasibility.

Rosita Bihariesingh-Sanchit, Rakesh Bansie, Angélique Bastienne van 't Wout, Rocade Ma, Dimitri Adriaan Diavatopoulos, Marien Isaäk de Jonge, Arno Pieter Nierich

Abstract read
In one paragraph

Article in Journal of global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rosita Bihariesingh-SanchitDepartment of Anesthesiology, Academic Hospital Paramaribo, Paramaribo, Suriname.
Rakesh BansieDepartment of Internal Medicine, Academic Hospital Paramaribo, Paramaribo, Suriname.
Angélique Bastienne van 't WoutAlphaBiomics Limited, Newcastle upon Tyne, UK.
Rocade MaDepartment of Anesthesiology, Academic Hospital Paramaribo, Paramaribo, Suriname.
Dimitri Adriaan DiavatopoulosRadboud Community for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
Marien Isaäk de JongeDepartment of Laboratory Medicine, Laboratory of Medical Immunology, Radboud University Medical Center, Nijmegen, the Netherlands.
Arno Pieter NierichDepartment of Anesthesiology, Academic Hospital Paramaribo, Paramaribo, Suriname.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Therapeutic plasma exchange (TPE) is a blood purification technique designed for the removal of large molecules such as pathogenic antibodies and lipoproteins. The procedure involves removing plasma from the patient in exchange for replacement fluid, and it can be performed either by membrane separation or centrifugation. These conventional techniques are expensive and require the training of skilled personnel. This severely limits their use in low-income countries (LICs) and lower-middle-income countries (LMICs), leading to morbidity and mortality for patients in LICs and LMICs suffering from the diseases where TPE is indicated. Methods: A novel gravity-driven blood separation method might provide the needed access to TPE for LICs and LMICs. We reviewed the medical need, the practical aspects, as well as the possible complications of applying this novel technology in LICs and LMICs. Furthermore, we describe a feasibility study of implementing TPE in Suriname for various diseases and conditions. Results: Where data was available (n /N = 10/11), supportive care combined with TPE using the new device resulted in improved values for the disease-specific markers evaluated in these patients. In addition, eight patients showed complete clinical recovery, and one patient showed partial clinical recovery upon TPE within 0.5-6 months of follow-up. Importantly, none of the patients experienced any serious side effects. Conclusions: This experience in the resource-limited setting in Suriname illustrates that its application is feasible in LICs and LMICs settings, at least for these five diseases with first-line indications for TPE and a significant number of patients.

Indexed as

Critical IllnessDeveloping CountriesPlasma ExchangeAdultFeasibility StudiesFemaleHumansMaleMiddle Aged

Identifiers

PMID40709581
PMCPMC12290984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.